Fibrinolysis associated with human neoplasia: Production of plasminogen activator by human tumours
✍ Scribed by Biserka Nagy; Jasna Ban; Branko Brdar
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- French
- Weight
- 555 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The plasminogen‐dependent fibrinolytic activity of several human tumours has been studied. The following neoplastic tissues, which were obtained from cancer patients by either surgery or biopsies, were examined: cervical, mammary, prostatic, ovarian, lung carcinomas, melanoma, basalioma. Fibrinolysis was measured in lysates either of tumour tissue specimens or of respective cell cultures. This measurement was based on release of radioactivity from ^125^I‐fibrin‐coated Petri dishes. All examined tumours showed elevated levels of plasminogen‐dependent fibrinolytic activity. However, normal control tissues had little or no activity. These results indicate that the fibrinolysis might be useful in differentiating between malignant and normal tissues.
📜 SIMILAR VOLUMES
## Abstract The ability of actinomycin D to interfere with the dexametha‐sone‐mediated inhibition of plasminogen activator (PA) production by human‐embryonic lung (HuEL) cells has been examined. The enzyme produced by HuEL cells in the presence of both dexamethasone and actinomycin D appears to be
## Abstract We have studied the estradiol sensitivity of primary human breast carcinomas in organ culture in a prospective pilot series of 109 tumors. The effect on plasminogen activator (PA) production was used as the end‐point of estrogen action. We found that: (i) All tumors secreted detectable